×

Biotech and Pharmaceuticals Pharmaceuticals

  • April 19- Martin Shkreli, the former drug company executive who drew public outcry when he raised the price of a life-saving drug by 5,000 percent, will be tried for securities fraud separately from a lawyer charged alongside him, a Brooklyn federal judge ruled Wednesday. Both Shkreli and lawyer Evan Greebel, who worked for Shkreli's former company Retrophin...

  • After a thorough and careful review of the allegations, the company and Bill OReilly have agreed that Bill OReilly will not be returning to the Fox News Channel, the company said in a statement. It is not known exactly how Fox News would handle O'Reilly's exit or whether he would be allowed to say goodbye to viewers on the air, according to the New York magazine...

  • NEW YORK, April 19- Fox News has decided to part ways with star host Bill O'Reilly following allegations of sexual harassment, New York magazine reported on Wednesday, citing anonymous sources briefed on the discussions. It is not known exactly how Fox News will handle O'Reilly's exit or whether he would be allowed to say goodbye to viewers on the air, according to...

  • NEW YORK, April 19- Fox News has decided to part ways with star host Bill O'Reilly following allegations of sexual harassment, New York magazine reported on Wednesday, citing anonymous sources briefed on the discussions. It is not known exactly how Fox News will handle O'Reilly's exit or whether he would be allowed to say goodbye to viewers on the air, according to...

  • intravenous saline solution

    The company had received grand jury subpoenas from the U.S. Justice Department amid an antitrust investigation.

  • *Merck, Bristol, Roche also have important upcoming news. LONDON, April 19- Three years after Pfizer's failed bid for AstraZeneca, the British drugmaker aims to prove in the coming weeks that its cancer immunotherapy can deliver on bold sales forecasts made during that takeover battle. "I think there will be multiple approvals in the first-line space," Naiyer Rizvi,...

  • Stocks ended the trading session more than 100 points lower on Tuesday

    The Dow dropped about 110 points and the S&P and Nasdaq both fell slightly.

  • April 18- U.S. generic drug company Argentum Pharmaceuticals LLC said on Tuesday it had reached an agreement with Allergan Plc that settles a patent dispute over the generic version of Allergan's eye drug, Restasis. The agreement gives Argentum the right to sell the copycat version of Restasis before the patents covering the drug expire, Argentum said.

  • *To buy Medtronic's units for $6.1 bln. Cardinal Health, which had forecast adjusted profit in the range of $5.35- $5.50 per share, expects generic price deflation to be in the low-double digits for its year ending June 30. "The weaker guidance, which includes the positive accretion from Medtronic's supply business, is concerning for the distributor sector," Mizuho...

  • April 18- U.S. drug distributor Cardinal Health Inc agreed to buy medical device maker Medtronic Plc's medical supplies units for $6.1 billion and said it expected full-year adjusted earnings at the lower end of its forecast. Cardinal Health, which had forecast adjusted profit in the range of $5.35- $5.50 per share, blamed generic price deflation for the...

  • GENEVA, April 18- Merck KGaA said it is developing a children's formula of its drug to treat schistosomiasis, a parasitic worm disease that infects millions of poor people in Africa and Asia. Schistosomiasis kills 280,000 people each year in Africa alone, the German drugmaker said on Tuesday. But the pill is large, bitter and difficult for children to swallow,...

  • Citing leaked internal emails, The Times newspaper reported staff at Aspen discussed destroying supplies of life-saving cancer medicines during a price dispute with the Spanish health service in 2014.. Aspen, Africa's largest generic drugmaker, declined to comment on specific allegations because it could be in breach of sub-judice laws that apply to...

  • April 17- Genentech, a unit of Swiss drugmaker Roche Holding AG, said on Monday it got approval from the U.S. Food and Drug Administration for its already approved immunotherapy drug, Tecentriq, to treat advanced bladder cancer. Tecentriq, also known as atezolizumab, received the go-ahead under the FDA's accelerated approval program as a first-line treatment...

  • FDA rejects LLY's rheumatoid arthritis drug

    CNBC's Meg Tirrell takes a look at what the FDA's rejection of the drug means for Eli Lilly and partner Incyte.

  • WASHINGTON, April 14- The U.S. Food and Drug Administration on Friday declined to approve a new drug for rheumatoid arthritis made by Eli Lilly and Co and partner Incyte Corp, the companies said on Friday. FDA indicated that additional clinical data was needed to determine the most appropriate doses of the drug, Olumiant, known also as baricitinib, and to further...

  • A lab worker at Spark Therapeutics in Philadelphia, PA.

    The "Fast Money" traders weigh biotech stocks as the sector gears up for blockbuster drugs and possible mergers.

  • April 13- Drug company Innoviva Inc said on Thursday it would undertake a review of its costs, including executive compensation following pressure from activist investor Sarissa Capital Management LP. The news comes two weeks after hedge fund Sarissa Capital called for a sharp cut in the compensation of Innoviva's chief executive and the board.

  • April 13- Drug company Innoviva Inc said on Thursday it would undertake a review of its costs, including executive compensation following pressure from activist investor Sarissa Capital Management LP. The news comes two weeks after hedge fund Sarissa Capital called for a sharp cut in the compensation of Innoviva's chief executive and the board.

  • LINCOLN, Neb.— A German pharmaceutical manufacturer whose drugs ended up in Nebraska's lethal injection supply never intended for state officials to obtain them and tried unsuccessfully to get the corrections department to return them, a company spokesman said Thursday. Nebraska's corrections department was only able to buy potassium chloride in 2015...

  • LITTLE ROCK, Ark.— Two pharmaceutical companies ask judge to block Arkansas from using its lethal injection drugs to execute seven inmates.